Sinovac, Institute for Translational Vaccinology, World Health Organization (WHO) deal

Sinovac will develop and commercialize Intravacc's Sabin inactivated polio vaccine under the public-private Global Polio Eradication Initiative. Sinovac will obtain regulatory approval for and launch the vaccine in China under a non-exclusive, worldwide license from Intravacc and will supply at least 20 million doses annually to other countries. Sinovac said Intravacc is eligible for undisclosed milestones and royalties. ...